CLINICAL TRIAL SUMMARY

MDACC Study No:2009-0556 (clinicaltrials.gov NCT No: NCT00976898)
Title:Phase II Study of Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma
Principal Investigator:Christopher H. Crane
Treatment Agent:Proton Therapy
Study Status:Open
Study Description:The goal of this clinical research study is to learn if proton beam radiation
therapy can shrink or slow the growth of the disease in patients with liver
cancer. The safety of this treatment will also be studied.

Hide details for General InformationGeneral Information

Disease Group:Gastrointestinal
Phase of Study:Phase II
Treatment Agents:Proton Therapy
Treatment Location:Both at MDACC & outside MDACC at one or more Collaborating Sites or Institutions
Estimated Length of Stay in Houston:n/a
Supported By:National Institutes of Health and Dana Farber/Partners Cancer Center (DF/PCC) on behalf of Massachusetts General Hospital and the Dana Farber/Harvard Cancer Center.
Return Visit:Weekly on-study labs are to be drawn on study days 1, 8, 15 and the day of the
last radiation
treatment. All patients will be evaluated initially and every three months for
two years, and every 6 months
thereafter for 3 years.
Home Care:n/a


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Christopher H. Crane
Dept:Radiation Oncology
For Clinical Trial Enrollment:713-563-2300
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults